Cite

HARVARD Citation

    Chu, M. et al. (2020). Body composition is prognostic and predictive of ipilimumab activity in metastatic melanoma. Journal of cachexia, sarcopenia and muscle. 11 (3), pp. 748-755. [Online]. 
  
Back to record